Equity in Focus Viaderma Inc (OTCMKTS:VDRM)

by Michael Brown | Last Updated: March 15, 2016

By entering your email address you agree to get email updates from Microcap Spotlight. We'll respect your privacy and unsubscribe at any time.

Viaderma Inc (OTCMKTS:VDRM) shares are going through the stratosphere locking in gains of over 20% for the day and 385% for the week. The stock has reached a new 52-week high and continues to climb on increasing volumes. Volume was almost 3x average daily volume with close to 2 million shares trading compared to an average of 781 thousand shares.

VDRM only has 137,000 shares outstanding according to google finance. The share price is currently at $0.00583 in the sub-penny levels. In February the stock was trading at a historic low of $0.002. VDRM has not posted SEC filings for their 10-K or 10-Qs since 2012 according to Google finance.. For investors hoping for a turnaround, this is the first step to gain credibility in the eyes of potential investors.

Looking at Yahoo Finance, VDRM recently released its June 2015 quarterly financial statements. The company posted negligible revenues and a loss of $23,000. The income statement was the only financial statement posted by VDRM so we do not have insight into the balance sheet but it is likely the company has very little cash on hand and a significant amount of outstanding liabilities.

VDRM is a company that operates out of China which in itself should raise a yellow flag to potential investors. Many investors were duped by fraudulent Chinese companies that did reverse mergers onto the US Stock Exchanges, leaving investors with significant losses and holding the bag once everything collapsed. According to its website, the company was founded in 2014 by Christopher Otiko. It is committed to bringing new products to market and licensing its technology and innovations. Their lead product is Testrastem, which allows almost any active ingredient to turn into a topical treatment drug for a delivery mechanism perspective.

We have a Monster Pick Coming. Subscribe Right Now!

Viaderma Inc (OTCMKTS:VDRM)

VDRM is currently trading at a $0.76 million market valuation. VDRM seems to be starting to stage a turnaround. If it can deliver on its innovations, register a patent with the USPTO, and begin licensing its technology or developing partnerships, this company will likely be in for more gains. Stay tuned for more updates on developments to make wiser financial decisions and not to be a bag holder, but rather capture gains and exit before the party stops.

We will be updating on VDRM when more details emerge so make sure you are subscribed to Microcapspot so you know what’s going on with VDRM.

Disclosure: we hold no position in VDRM either long or short and we have not been compensated for this article.

Subscribe To Microcap Newsletter

By entering your email address you agree to get email updates from Microcap Spotlight. We'll respect your privacy and unsubscribe at any time.